Table 1.
Clinical data, hematological, and immunological characteristics of HIV-infected patients.
Characteristic (mean ± s.d.) | HIV-infection patients in stage A (CDC, 1993) |
||
---|---|---|---|
Group 1 (n = 100) | Group 2 (n = 15) | Group 3 (n = 15) | |
Age (years) | 32 ± 4.3 | 31 ± 5.8 | 31 ± 5.8 |
Sex (F/M) | 0/100 | 0/15 | 0/15 |
Antiviral treatment | 0 | 0 | 0 |
Duration of HIV (months) | 31 ± 12.3 | 28 ± 10.1 | 28 ± 10.1 |
HIV-1 risk factor (IDU) | 100 | 15 | 15 |
CD4 (cells/µL) | 238.4 ± 58.9 | 241.1 ± 52.3 | 241.1 ± 52.3 |
CD8 (cells/µL) | 997.0 ± 128.3 | 934.2 ± 157.6 | 934.2 ± 157.6 |